Candel Therapeutics logo

Candel Therapeutics

CADL | NASDAQ
Chart Builder DCF Calculator
$5.81
-$0.39 (-6.29%)
At close: Nov 16, 2026, 4:00 PM ET
$5.76
-$0.05 (-0.86%)
After-hours: Nov 16, 2026, 7:55 PM ET
-6.29%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
34.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #661/1021 (Top 65%)

Key Statistics

Market Data

Market Cap $455.77M
1D Range
5.73 6.23
52W Range
4.42 13.75

Valuation (TTM)

PE -3.93
PB 3.46
EV/EBITDA -2.68

Valuation (NTM)

Forward PE N/A
Forward PEG -0.02
Price Target $23.00
Loading financial charts...

Profile

Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical firm based in Needham, Massachusetts, dedicated to developing innovative immunotherapies for cancer patients. Its pipeline features CAN-...

Sector Healthcare
Industry Biotechnology
Employees 55
IPO Date Jul 27, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
6
Consensus
Buy
Price Target
$23.00
Upside
+295.87%
Buy (6)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.